Evaluation of cyclophosphamide treatment of systemic sclerosis-associated pulmonary dysfunction: comment on the article by Akesson et al.
Bicknell
S
S
Menon
N
N
Madhok
R
R
D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008171:Lung Diseases / Q000150:complications* / Q000188:drug therapy*; D015203:Reproducibility of Results; D012595:Scleroderma, Systemic / Q000150:complications*
D003520:Cyclophosphamide